Knee Replacement Surgery Companies

The global knee replacement surgery market is expected to reach USD 16.17 billion by 2030 from USD 12.00 billion in 2025, at a CAGR of 6.1% from 2025 to 2030. The rising prevalence of osteoarthritis and emerging business opportunities in developing economies are significantly accelerating the demand for knee devices. Recent technological advancements, such as robotic-assisted surgical procedures, the development of patient-specific implants, and an emphasis on minimally invasive techniques, enhance patient outcomes and overall satisfaction rates. Additionally, improved accessibility to healthcare services in developing regions, alongside the burgeoning medical tourism industry, is contributing to the expansion of the knee replacement surgery market. It is important to note that this market remains relatively consolidated, reflecting a concentrated competitive landscape.

As of 2024, the key players operating in the global knee replacement surgery market are Zimmer Biomet (US), Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany).

To know about the assumptions considered for the study download the pdf brochure

Stryker US) ranks among the top firms in the global knee replacement surgery market. The organization has established a formidable presence in the global market, extending its operational reach across key regions, including Europe, North America, the Middle East, Africa, and the Asia Pacific. With a successful track record in more than 75 countries, the company has effectively built a strong brand recognition, particularly through its Orthopedics division, which specializes in advanced surgical devices for knee treatments. Driven by a commitment to growth, the firm continuously seeks to broaden its product portfolio, ensuring that it remains at the forefront of innovation by launching groundbreaking solutions tailored to meet the evolving demands of the market. To maintain its competitive advantage, the organization places a high priority on innovation and the creation of unique, differentiated products that stand out in an increasingly crowded marketplace. A central element of its strategy is a substantial investment in R&D, which fuels the introduction of pioneering technologies. These advancements are specifically designed to address the pressing, unmet needs of healthcare providers and patients, thereby enhancing treatment outcomes and improving the quality of care within the healthcare system.

Zimmer Biomet (US) is among the leading companies in the global knee replacement surgery market.  The firm is a key player in the healthcare industry, specializing in the production and distribution of a diverse range of medical devices and healthcare products designed to meet various medical needs. With a robust presence across multiple international markets, the company operates in notable countries such as Germany, where it taps into a highly developed healthcare system; France, which is known for its emphasis on innovation in medicine; and Italy, which has a rich history of medical advancements. In addition to these European nations, the firm's influence extends to Switzerland, renowned for its high-quality healthcare, as well as Spain and the UK, both of which represent significant markets for medical technology. The firm also maintains a strong foothold in Asia, including major economies such as Japan and South Korea, which are recognized for their cutting-edge healthcare technologies. Further expanding its global reach, the firm has established a presence in China, one of the fastest-growing healthcare markets in the world, as well as in Australia and New Zealand, where it provides vital healthcare solutions. The company is also active in Taiwan, India, Hong Kong, Thailand, Singapore, and Malaysia, where it meets the diverse medical needs of these dynamic populations. To support its extensive operations, the firm has developed a comprehensive distribution network that spans Benelux (Belgium, Netherlands, and Luxembourg) and the Nordic countries, ensuring effective market penetration in Central and Eastern Europe. Additionally, the firm has made significant inroads in the Middle East and Africa, regions that are increasingly recognizing the importance of advanced medical technology in improving healthcare outcomes. This strategic global presence not only enhances the firm's competitiveness but also reinforces its commitment to advancing healthcare worldwide.

Johnson & Johnson Services, Inc. (US) is a prominent entity within the knee replacement surgery sector, engaged in the comprehensive manufacturing, R&D, and global marketing of joint replacement technologies and related healthcare products. Operating under the MedTech business segment, it specializes in advancing knee replacement surgery products aimed at improving clinical outcomes through innovative technology.  In a strategic collaboration with CrossRoads Extremity Systems (US), the company is focused on enhancing orthopedic care by integrating novel ideas to provide patients with superior health benefits. The firm commands a substantial market share across more than 60 countries, spanning multiple regions, including Asia Pacific, North America, the Middle East & Africa, and Europe. Additionally, it operates through a robust portfolio of key subsidiaries, which includes DePuy, Inc. (US), Animas Corporation (US), Ethicon, Inc. (US), and LifeScan, Inc. (US).

Market Ranking, 2024

The global knee replacement surgery market is consolidated with the top five players—Zimmer Biomet (US), Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany). Players in the knee replacement surgery market were identified through secondary research, and their market shares (in terms of value) were evaluated based on several aspects, such as the products provided, segmental revenue analysis, geographic presence, recent market developments, and market positioning. Primary research interviews were conducted with key opinion leaders in the industry, such as chief executive officers, directors, industry experts, and other executives, to validate revenues and market shares.

The primary stakeholders in the market are predominantly located in the US. Notable advantages enjoyed by the leading market players include enhanced marketing and distribution frameworks, significant R&D investments, and elevated brand recognition. The competitive landscape also reveals a substantial presence of numerous smaller enterprises that cater to both regional and global markets. Companies are intensifying their focus on R&D initiatives to diversify their product portfolios and strengthen their competitive positions. Moreover, there is a clear incentive for market participants to expand their footprint in the Asia Pacific and Latin American regions, driven by the attractive growth opportunities these markets present.

Related Reports:

Knee Replacement Surgery Market by Procedure Type (Knee Replacement: Total, Partial, Revision), Product (Implants: Hybrid, Plastic, Metal or Ceramic; Orthobiologic, Braces), Application (Arthritis, Cancer), End User (Clinics, ASCs) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com